Table 1.
Clinical characteristics
| Non-diabetic | Type 1 Diabetes | Type 2 Diabetes | |
|---|---|---|---|
| n (%) | 299 (3.9) | 1,049 (13.7) | 6,328 (82.4) |
| Age, median (IQR) | 62 (53; 70) | 59 (47; 68) | 67 (59; 74) |
| BMI, median (IQR) | 26.0 (23.6; 29.4) | 25.7 (23.2; 29.0) | 29.5 (26.2; 33.6) |
| Sex, n (%) | |||
| Female | 195 (65.2) | 465 (44.3) | 2,466 (39.0) |
| Male | 104 (34.8) | 580 (55.3) | 3,848 (60.8) |
| Other | 0 (0.0) | < 5 (.) | 14 (0.2) |
| Disease duration, median (IQR) | 26 (12; 40) | 10 (4; 15) | |
| Education, n (%) | |||
| Municipal primary/lower secondary school (10 years) | 32 (13.6) | 230 (25.4) | 1,978 (35.1) |
| Upper secondary school/Academy profession graduate (11–15 years) | 19 (8.1) | 97 (10.7) | 472 (8.4) |
| University graduate, BSc/MSc (16 ≥ years) | 185 (78.4) | 579 (63.9) | 3,178 (56.5) |
| Income, n (%) | |||
| Low | 47 (15.7) | 244 (23.3) | 1,756 (27.7) |
| Middle | 91 (30.4) | 318 (30.3) | 2,044 (32.3) |
| High | 105 (35.1) | 266 (25.4) | 1,105 (17.5) |
| Unknown | 56 (18.7) | 221 (21.1) | 1,423 (22.5) |
| COMPASS-31 total, median (IQR) | 6.8 (2.8; 16.9) | 8.9 (3.0; 22.5) | 12.5 (5.3; 26.4) |
| Moderate/severe symptoms, % (95% CI) | |||
| Orthostatic intolerance | 14.4 (10.6–18.9) | 24.0 (21.5–26.7) | 26.3 (25.2–27.4) |
| Secretomotor | 5 (2.8–8.1) | 11.2 (9.3–13.2) | 10.3 (9.5–11.0) |
| Vasomotor | 8.7 (5.8–12.5) | 12.3 (10.3–14.4) | 15.8 (14.9–16.7) |
| Gastrointestinal | 7.4 (4.7–10.9) | 9.3 (7.6–11.2) | 12.3 (11.5–13.2) |
| Bladder | 7.7 (4.9–11.3) | 12.4 (10.5–14.6) | 19.8 (18.8–20.8) |
| Pupillary | 36.5 (31.0-42.2) | 38.4 (35.5–41.4) | 32.8 (31.7–34.0) |
IQR: interquartile range, BMI: body mass index, CI: confidence interval